LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
LIPELLA PHARMACEUTICALS INC.
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $2.27K
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Lipella Pharmaceuticals has not reported a dividend
No dividend per share appears in Lipella Pharmaceuticals's annual filings since fiscal 2020.